Thursday, 6 February 2025

Sandoz Canada

News Release

Introducing Jubbonti® and Wyost®, the first denosumab biosimilars on the Canadian market

— Jubbonti® and Wyost® are first denosumab biosimilars available in Canada, reflecting the Sandoz Purpose of pioneering access for patients — Jubbonti® and...

News Release

Sandoz Canada achieves carbon neutral certification for its commercial operations

Sandoz Canada head office and sales force operations certified carbon neutral by LCL Engineering, Environment & Sustainable DevelopmentCO2 emissions offset through the purchase...

Login into your Account

Please login to like, dislike or bookmark this article.